Malagnino, V., Teti, E., Compagno, M., Coppola, L., Salpini, R., Svicher, V., et al. (2021). HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. MICROORGANISMS, 9(2), 1-13 [10.3390/microorganisms9020396]. Dettagli
10.3390/microorganisms9020396
CitazioneMalagnino, V., Teti, E., Compagno, M., Coppola, L., Salpini, R., Svicher, V., et al. (2021). HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. MICROORGANISMS, 9(2), 1-13 [10.3390/microorganisms9020396].Data2021idPUBBLICAZIONE_413247TipologiaArticolo su rivistaSSDSettore MED/04Tutti gli AutoriHBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian CohorttipologiaMalagnino, V; Teti, E; Compagno, M; Coppola, L; Salpini, R; Svicher, V; Basso, M; Battagin, G; Panese, S; Cristina Rossi, M; Scaggiante, R; Zago, D; Iannetta, M; Giuseppe Parisi, S; Andreoni, M; Sarmati, L